Mutationcs.AIDisease Models, AnimalHomozygoteactivationCalreticulinCell Cycle CheckpointsCell Transformation, NeoplasticComputational Biologycryo-EM

On Valency

published · living versions
W_63ueycek·v1 · currentpublished
Discovering Language Model Behaviors with Model-Written Evaluations
with Ethan Perez, Sam Ringer, Kamilė Lukošiūtė, Karina Nguyen +58
1 version

Preprints & journals

34 papers in the corpus · 2000–2026
The Hierarchy of Agentic Capabilities: Evaluating Frontier Models on Realistic RL Environments2601.09032v1 · Logan Ritchie, Sushant Mehta, Nick Heiner et al.2026 · 0 citationsarXiv
Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.39443719 · Schneider, Rebekka K, Schenone, Monica, Ferreira, Monica Ventura et al.2024 · 1 citationNature medicine. 2024;30(11):3382
Discovering Language Model Behaviors with Model-Written Evaluations2212.09251v1 · Ethan Perez, Sam Ringer, Kamil\.e Lukosi\=ut\.e et al.2022 · 224 citationsarXivon Valency
Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis.33821991 · Rivera, Jeanne F, Baral, April J, Nadat, Fatima et al.2021 · 14 citationsBlood advances. 2021;5(7):1922-1932
Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML.33351783 · Tothova, Zuzana, Valton, Anne-Laure, Gorelov, Rebecca A et al.2021 · 94 citationsJCI insight. 2021;6(3)
Mechanism of completion of peptidyltransferase centre assembly in eukaryotes.31115337 · Kargas, Vasileios, Castro-Hartmann, Pablo, Escudero-Urquijo, Norberto et al.2020 · 71 citationseLife. 2019;8
Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN.29288169 · Elf, Shannon, Abdelfattah, Nouran S, Baral, April J et al.2019 · 92 citationsBlood. 2018;131(7):782-786
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.26951227 · Elf, Shannon, Abdelfattah, Nouran S, Chen, Edwin et al.2016 · 299 citationsCancer discovery. 2016;6(4):368-81
STAT1 activation in association with JAK2 exon 12 mutations.26635038 · Godfrey, Anna L, Chen, Edwin, Massie, Charles E et al.2016 · 17 citationsHaematologica. 2016;101(1):e15-9
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.26686625 · Chen, Edwin, Ahn, Jong Sook, Sykes, David B et al.2016 · 31 citationsCell reports. 2015;13(11):2345-2352
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.26878232 · Schneider, Rebekka K, Schenone, Monica, Ferreira, Monica Ventura et al.2016 · 256 citationsNature medicine. 2016;22(3):288-97
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.25849990 · Tapper, William, Jones, Amy V, Kralovics, Robert et al.2016 · 169 citationsNature communications. 2015;6:6691
How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?25696866 · Chen, Edwin, Mullally, Ann2015 · 46 citationsHematology. American Society of Hematology. Education Program. 2014;2014(1):268-76
Postnatal Notch1 activation induces T‑cell malignancy in conditional and inducible mouse models.25175815 · Liu, Ju, Dong, Fengyun, Fung, Iris et al.2015 · 0 citationsInternational journal of oncology. 2014;45(5):1997-2004
JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response.25288776 · Chen, Edwin, Ahn, Jong Sook, Massie, Charlie E et al.2015 · 51 citationsProceedings of the National Academy of Sciences of the United States of America. 2014;111(42):15190-5
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms.25281607 · Chen, Edwin, Schneider, Rebekka K, Breyfogle, Lawrence J et al.2015 · 105 citationsBlood. 2015;125(2):327-35
Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK.24586935 · Krutikov, Konstantin, Zheng, Yanzhen, Chesney, Alden et al.2015 · 2 citationsPloS one. 2014;9(2):e89649
JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.24692758 · Li, Juan, Kent, David G, Godfrey, Anna L et al.2014 · 96 citationsBlood. 2014;123(20):3139-51
Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia.23633544 · Godfrey, Anna L, Chen, Edwin, Pagano, Francesca et al.2013 · 41 citationsHaematologica. 2013;98(5):718-21
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.22898600 · Godfrey, Anna L, Chen, Edwin, Pagano, Francesca et al.2013 · 108 citationsBlood. 2012;120(13):2704-7
The transcription factor encyclopedia.22458515 · Yusuf, Dimas, Butland, Stefanie L, Swanson, Magdalena I et al.2012 · 160 citationsGenome biology. 2012;13(3):R24
Janus kinase deregulation in leukemia and lymphoma.22520846 · Chen, Edwin, Staudt, Louis M, Green, Anthony R2012 · 126 citationsImmunity. 2012;36(4):529-41
Mouse models of myeloproliferative neoplasms: JAK of all grades.21558064 · Li, Juan, Kent, David G, Chen, Edwin et al.2011 · 97 citationsDisease models & mechanisms. 2011;4(3):311-7
Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1.20846384 · Chen, Edwin, Huang, Xiaoyong, Zheng, Yanzhen et al.2011 · 4 citationsMolecular cancer. 2010;9:246
Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.21074499 · Chen, Edwin, Beer, Philip A, Godfrey, Anna L et al.2010 · 175 citationsCancer cell. 2010;18(5):524-35
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.20489053 · Li, Juan, Spensberger, Dominik, Ahn, Jong Sook et al.2010 · 209 citationsBlood. 2010;116(9):1528-38
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.20008300 · Beer, Philip A, Delhommeau, François, LeCouédic, Jean-Pierre et al.2010 · 309 citationsBlood. 2010;115(14):2891-900
ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling.19571317 · Wood, Andrew D, Chen, Edwin, Donaldson, Ian J et al.2009 · 49 citationsBlood. 2009;114(9):1820-30
Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.16862188 · Chen, E, Kwon, Y T, Lim, M S et al.2006 · 14 citationsOncogene. 2006;25(42):5752-63
Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice.16407851 · Chen, E, Lim, M S, Rosic-Kablar, S et al.2006 · 18 citationsOncogene. 2006;25(18):2575-87
Gene expression profiling in the inductive human hematopoietic microenvironment.15369807 · Zhao, Yongjun, Chen, Edwin, Li, Liheng et al.2004 · 3 citationsBiochemical and biophysical research communications. 2004;323(2):703-11
Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice.11294870 · Khalyfa, A, Bourbeau, D, Chen, E et al.2001 · 104 citationsThe Journal of biological chemistry. 2001;276(25):22915-22
Rapid up-regulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis.10942586 · Chen, E, Proestou, G, Bourbeau, D et al.2000 · 110 citationsExperimental cell research. 2000;259(1):140-8
Career total: 64 works. 34 are in this corpus.

Profile built from the corpus for this byline.

Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.